BMSD : 10.65048
BMSD : 10.65048
https://doi.org/10.65048/ijbmr
Search
About Us
Authors
Reviewers
Editorial Board
Contact Us

International Journal of Biological and Medical Research (IJBMR)

Review Article
Year : 2026  |  Volume : 17  |  Issue : 3  |  Page : 8681-8684 Full Version
Plasma and urine metabolite panels for early sepsis diagnosis and risk stratification in the icu:an integrated review of ms-based metabolomics workflow and clinical translation barriers
Int J Biol Med Res. 2026; 17(3): 8681-8684  |  DOI: 10.65048/ijbmr.2026.17.3.8681.1071
Dr. Atul Khajuria, Humaira Zahoor
Dean, Faculty of Allied & Healthcare Sciences , Rayat Bahra Professional University, Hoshiarpur, Punjab, India
Correspondence Address :
Dr. Atul Khajuria,
Dean, Faculty of Allied & Healthcare Sciences
Rayat Bahra Professional University, Hoshiarpur,
Punjab, India. E-mail: atulkhajuria83@gmail.com
Received: February 9, 2026 Accepted: April 23, 2026 Published: July 3, 2026

Abstract
Background: Early diagnosis and risk stratification of sepsis in the intensive care unit (ICU) remain major clinical challenges. Conventional biomarkers such as lactate, procalcitonin, and C-reactive protein lack sufficient specificity and prognostic resolution. Mass spectrometry (MS)–based metabolomics has emerged as a promising platform for identifying plasma and urine metabolite panels capable of reflecting host metabolic reprogramming during early sepsis. Methods: This review synthesizes evidence from studies published between 2000 and 2024 evaluating plasma and urine metabolite signatures for early sepsis diagnosis and ICU risk stratification. We examine MS-based workflows, analytical platforms (LC-MS, GC-MS, HRMS), statistical modeling strategies, and translational barriers. Results: Consistent alterations in amino acid metabolism (arginine, tryptophan, phenylalanine), lipid mediators (lysophosphatidylcholines, acylcarnitines), glycolytic intermediates, and TCA cycle metabolites have been reported. Several multivariate metabolite panels demonstrate AUC values >0.85 for early diagnosis and mortality prediction. However, inter-study variability, lack of external validation, preanalytical heterogeneity, and regulatory barriers limit clinical translation. Conclusions: Plasma and urine metabolite panels show strong potential for early sepsis detection and ICU risk stratification. Standardization of workflows, multicenter validation, and integration with clinical decision tools are essential for translation into routine care.
Keywords
Intensive Care Unit (ICU), C-reactive protein, Mass spectrometry(MS)


IJBMR -ISSN: 0976:6685. ©Copyright 2026 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Published by BioMedSciDirect Publications